Progression independent of relapse activity (PIRA) is associated with accelerated retinal atrophy in patients with relapsing remitting multiple sclerosis

被引:0
|
作者
Strauss, Eva-Maria [1 ]
Aly, Lilian [1 ]
Berthele, Achim [1 ]
Lambrecht, Sebastian [1 ]
Hemmer, Bernhard [1 ,2 ]
Knier, Benjamin [1 ]
机构
[1] Tech Univ Munich, TUM Sch Med, Dept Neurol, Klinikum Rechts Isar, Munich, Germany
[2] Munich Cluster Syst Neurol SyNergy, Munich, Germany
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P389/3181
引用
收藏
页码:1075 / 1076
页数:2
相关论文
共 50 条
  • [1] Progression independent of relapse activity is associated with increased brain atrophy rates in patients with relapsing-remitting multiple sclerosis
    Cagol, A.
    Schaedelin, S.
    Barakovic, M.
    Benkert, P.
    Todea, R. -A.
    Rahmanzadeh, R.
    Galbusera, R.
    Lu, P. -J.
    Weigel, M.
    Melie-Garcia, L.
    Ruberte, E.
    Radue, E. -W.
    Yaldizli, O.
    Oechtering, J.
    Sinnecker, T.
    Lorscheider, J.
    Mueller, S.
    Achtnichts, L.
    Vehoff, J.
    Disanto, G.
    Findling, O.
    Chan, A.
    Salmen, A.
    Pot, C.
    Bridel, C.
    Zecca, C.
    Derfuss, T.
    Lieb, J. M.
    Remonda, L.
    Wagner, F.
    Vargas, M.
    Du Pasquier, R.
    Lalive, P.
    Pravata, E.
    Weber, J.
    Gobbi, C.
    Leppert, D.
    Kappos, L.
    Kuhle, J.
    Granziera, C.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 98 - 99
  • [2] Defining progression independent of relapse activity (PIRA) in adult patients with relapsing multiple sclerosis: A systematic review
    Sharrad, Dale
    Chugh, Pooja
    Slee, Mark
    Bacchi, Stephen
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 78
  • [3] Motor evoked potentials predict progression independent of relapse activity (PIRA) in relapsing multiple sclerosis
    Michal, Zido
    Hofer, Lisa
    Benkert, Pascal
    Schadelin, Sabine
    Kuhle, Jens
    Hardmeier, Martin
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 168 - 169
  • [4] Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis
    Cagol, Alessandro
    Schaedelin, Sabine
    Barakovic, Muhamed
    Benkert, Pascal
    Todea, Ramona-Alexandra
    Rahmanzadeh, Reza
    Galbusera, Riccardo
    Lu, Po-Jui
    Weigel, Matthias
    Melie-Garcia, Lester
    Ruberte, Esther
    Siebenborn, Nina
    Battaglini, Marco
    Radue, Ernst-Wilhelm
    Yaldizli, Ozgur
    Oechtering, Johanna
    Sinnecker, Tim
    Lorscheider, Johannes
    Fischer-Barnicol, Bettina
    Mueller, Stefanie
    Achtnichts, Lutz
    Vehoff, Jochen
    Disanto, Giulio
    Findling, Oliver
    Chan, Andrew
    Salmen, Anke
    Pot, Caroline
    Bridel, Claire
    Zecca, Chiara
    Derfuss, Tobias
    Lieb, Johanna M.
    Remonda, Luca
    Wagner, Franca
    Vargas, Maria, I
    Du Pasquier, Renaud
    Lalive, Patrice H.
    Pravata, Emanuele
    Weber, Johannes
    Cattin, Philippe C.
    Gobbi, Claudio
    Leppert, David
    Kappos, Ludwig
    Kuhle, Jens
    Granziera, Cristina
    JAMA NEUROLOGY, 2022, 79 (07) : 682 - 692
  • [5] Risk factors associated with persistent progression independent of relapse activity (PIRA), and the association of persistent PIRA with disability progression in multiple sclerosis
    Zhu, Chao
    Zhou, Zhen
    Kalincik, Tomas
    Roos, Izanne
    Buzzard, Katherine
    Skibina, Olga
    Alroughani, Raed
    Izquierdo, Guillermo
    Eichau, Sara
    Kuhle, Jens
    Grand'Maison, Francois
    Prat, Alexandre
    Girard, Marc
    Duquette, Pierre
    Lechner-Scott, Jeannette
    Barnett, Michael
    Gerlach, Oliver
    Merlo, Daniel
    Monif, Mastura
    Jokubaitis, Vilija G.
    van der Walt, Anneke
    Butzkueven, Helmut
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 51 - 53
  • [6] Utility of Progression Independent of Relapse Activity as a Trial Outcome in Relapsing-Remitting Multiple Sclerosis
    Strijbis, Eva M. M.
    Mostert, Jop
    Comtois, Jacynthe
    Salter, Amber
    Repovic, Pavle
    Bowen, James D.
    Uitdehaag, Bernard M. J.
    Cutter, Gary R.
    Koch, Marcus W.
    NEUROLOGY, 2025, 104 (02)
  • [7] Quality of life is decreased early on in patients with relapsing remitting multiple sclerosis experiencing progression independent of relapse activity
    Lindberg, Sarah
    Sandgren, Sofia
    Axelsson, Markus
    Novakova, Lenka
    Lycke, Jan
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 161 - 161
  • [8] Thalamus pathology but not retinal pathology predicts early progression independent relapse activity (PIRA) in early multiple sclerosis patients
    Bollo, Luca
    Pareto, Deborah
    Tur, Carmen
    Carbonell, Pere
    Alberich, Manel
    Cabello, Sergio
    Arrambide, Georgina
    Cobo Calvo, Alvaro
    Villacieros-Alvarez, Javier
    Zabalza, Ana
    Carvajal, Rene
    Arino, Helena
    Zancan, Valeria
    Tagliani, Paula
    Vilaseca, Andreu
    Pappolla, Agustin
    Sarreon, Alexis
    Mongay-Ochoa, Neus
    Rodriguez, Breogan
    Castillo-Justribo, Joaquin
    Midaglia, Luciana
    Galan, Ingrid
    Rio, Jordi
    Comabella, Manuel
    Auger, Cristina
    Rovira Canellas, Alex
    Sastre-Garriga, Jaume
    Tintore, Mar
    Montalban, Xavier
    Vidal-Jordana, Angela
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 95 - 97
  • [9] Progression independent of relapse activity (PIRA) in relapsing-remitting multiple sclerosis patients on first-line immunomodulatory treatment with fingolimod vs. platform injectables
    von Wyl, V.
    Benkert, P.
    Lorscheider, J.
    Hanni, P.
    Lienert, C.
    Decard, B.
    Kuhle, J.
    Derfuss, T.
    Kappos, L.
    Yaldizli, O.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 381 - 382
  • [10] Progression independent of relapse activity (PIRA) in relapsing-remitting multiple sclerosis patients on injectable vs oral first line Disease Modifying Therapies: an Italian MS registry study
    Zanghi, A.
    Avolio, C.
    Amato, M. P.
    Filippi, M.
    Trojano, M.
    D'Amico, E.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 976 - 977